Skip to content
healthcare.dev

Dapsone

NDC 64980-567, dapsone, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-567
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207165
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPSONE25 mg/1

Pharmacologic classes

Sulfone [EPC]; Sulfones [CS]

Package NDCNDC-11Package
64980-567-0164980056701100 TABLET in 1 BOTTLE (64980-567-01)
64980-567-036498005670330 TABLET in 1 BOTTLE (64980-567-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e369b26d-219a-4e23-b8d4-f94048d36acd
  • NADAC price for package 64980056701

    GET /v1/drugs/nadac/64980056701
  • NADAC price for package 64980056703

    GET /v1/drugs/nadac/64980056703

Use it

Look up 64980-567 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-567. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.